Effects of colostrum supplements on physical performance and cognitive function in diabetes patients
The Value of Using Colostrum Supplements on the Physical Performance and Cognitive Function in Healthy Subjects and Type 2 Diabetes: A Case-management Comparative Study
PHASE2 · Al-Mustafa University College · NCT06007430
This study is testing whether colostrum supplements can improve physical performance and brain function in people with Type 2 Diabetes compared to a placebo.
Quick facts
| Phase | PHASE2 |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Al-Mustafa University College (other) |
| Locations | 1 site (Wasit) |
| Trial ID | NCT06007430 on ClinicalTrials.gov |
What this trial studies
This interventional clinical trial aims to evaluate the impact of colostrum supplements compared to a placebo on various health parameters in Iraqi participants with Type 2 Diabetes Mellitus. The study will measure changes in inflammatory markers, blood glucose levels, HbA1C, body mass index, lipid profiles, and other hematological indices over a 60-day period. Participants will be divided into groups receiving either colostrum or placebo, allowing for a direct comparison of effects. The trial seeks to provide insights into the potential benefits of colostrum on both physical and cognitive functions in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-70 diagnosed with Type 2 Diabetes Mellitus or healthy individuals for control.
Not a fit: Patients with Type 1 Diabetes Mellitus, those with significant co-morbidities, or women who are pregnant or planning to conceive may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could offer a novel dietary supplement to improve physical performance and cognitive function in patients with Type 2 Diabetes Mellitus.
How similar studies have performed: While the specific use of colostrum in this context may be novel, similar studies exploring dietary supplements for diabetes management have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Apparently Healthy patients for control * Patients diagnosed with T2DM * Age between 18-70 Exclusion Criteria: * Patients with T1DM * Patients with a drug history of anabolic substances for more than 14 days duration. * Patients with co-morbidities (e.g. CVS, renal, hepatic, and endocrine disorders) * Pregnancy, lactation, or female patient willing for conception.
Where this trial is running
Wasit
- Al-Zahraa Teaching Hospital — Wasit, Iraq (RECRUITING)
Study contacts
- Principal investigator: Ahmed Khalid Mohammed Albasri, MSc — Al-Farabi Kazakh National University
- Study coordinator: Ahmed Khalid Mohammed Albasri, MSc
- Email: ahmedalbasri28@gmail.com
- Phone: +9647812831612
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Diabetes Mellitus, Type 2, Colostrum, Cognition, Physical Functional Performance